Eric Fleming's questions to ICU Medical Inc (ICUI) leadership • Q3 2024
Question
Eric Fleming of Raymond James inquired about pricing sustainability for the Plum Duo infusion system, competitive market share dynamics, the potential impact of the Mexican peso, and the resolution status of the FDA warning letter.
Answer
Executive Vivek Jain stated that the company is holding firm on Plum Duo pricing to reflect its technological value and feels confident in its competitive position with the Duo and upcoming Solo systems. He noted the impact of the Mexican peso is unclear but not a primary focus. Importantly, Jain confirmed a successful FDA follow-up inspection at the Minneapolis site (with no observations), a key step toward resolving the warning letter, though the final report is still pending.